BR0013127A - Cassete de expressão, vetor recombinante, microorganismo, planta transgênica, método para gerar plantas transgênicas, usos de um vetor de um microorganismo, de um cassete de expressão, ou de uma planta transgênica, e, processo para a preparação de tocoferóis - Google Patents
Cassete de expressão, vetor recombinante, microorganismo, planta transgênica, método para gerar plantas transgênicas, usos de um vetor de um microorganismo, de um cassete de expressão, ou de uma planta transgênica, e, processo para a preparação de tocoferóisInfo
- Publication number
- BR0013127A BR0013127A BR0013127-0A BR0013127A BR0013127A BR 0013127 A BR0013127 A BR 0013127A BR 0013127 A BR0013127 A BR 0013127A BR 0013127 A BR0013127 A BR 0013127A
- Authority
- BR
- Brazil
- Prior art keywords
- microorganism
- expression cassette
- transgenic plant
- vector
- protection
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19937957A DE19937957A1 (de) | 1999-08-11 | 1999-08-11 | Homogentisat-Dioxygenase |
PCT/EP2000/007807 WO2001012827A2 (de) | 1999-08-11 | 2000-08-10 | Verfahren zur herstellung transgener pflanzen mit erhöhtem tocopherol-gehalt |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0013127A true BR0013127A (pt) | 2002-04-23 |
Family
ID=7917993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0013127-0A BR0013127A (pt) | 1999-08-11 | 2000-08-10 | Cassete de expressão, vetor recombinante, microorganismo, planta transgênica, método para gerar plantas transgênicas, usos de um vetor de um microorganismo, de um cassete de expressão, ou de uma planta transgênica, e, processo para a preparação de tocoferóis |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1200598A2 (de) |
AR (1) | AR029762A1 (de) |
AU (1) | AU6440900A (de) |
BR (1) | BR0013127A (de) |
CA (1) | CA2381316A1 (de) |
DE (1) | DE19937957A1 (de) |
WO (1) | WO2001012827A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2253220T3 (es) | 1999-04-15 | 2006-06-01 | Calgene Llc | Secuencias de acido nucleico de proteinas implicadas en la sintesis de tocoferol. |
US6872815B1 (en) | 2000-10-14 | 2005-03-29 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
DE60140312D1 (en) | 2000-08-07 | 2009-12-10 | Monsanto Technology Llc | Am methyl-d-erythriol phosphat reaktionsweg beteiligte gene |
DE10046462A1 (de) * | 2000-09-19 | 2002-05-29 | Sungene Gmbh & Co Kgaa | Verbesserte Verfahren zur Vitamin E Biosynthese |
US7161061B2 (en) | 2001-05-09 | 2007-01-09 | Monsanto Technology Llc | Metabolite transporters |
DE60230608D1 (de) | 2001-05-09 | 2009-02-12 | Monsanto Technology Llc | Tyra-gene und ihre verwendung |
EP1427832A4 (de) | 2001-08-17 | 2006-09-06 | Monsanto Technology Llc | Methyltransferasegene und verwendungen davon |
AU2002342114B2 (en) | 2001-10-25 | 2008-07-31 | Monsanto Technology Llc | Aromatic methyltransferases and uses thereof |
BRPI0308740B1 (pt) | 2002-03-19 | 2018-11-21 | Monsanto Technology Llc | molécula de ácido nucléico codificando uma homogentisato prenil transferase (“hpt”) e método de produzir planta tendo semente com nível de tocoferol aumentado |
US7230165B2 (en) | 2002-08-05 | 2007-06-12 | Monsanto Technology Llc | Tocopherol biosynthesis related genes and uses thereof |
GB2595633A (en) * | 2020-04-15 | 2021-12-08 | Univ Liverpool | Anti-infective agents |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA199900150A1 (ru) * | 1996-07-25 | 2000-04-24 | Америкэн Сиэнамид Компани | Ген hppd и ингибиторы |
DE19730066A1 (de) * | 1997-07-14 | 1999-01-21 | Basf Ag | DNA-Sequenz codierend für eine Hydroxyphenylpyruvatdioxygenase und deren Überproduktion in Pflanzen |
FR2778527A1 (fr) * | 1998-05-18 | 1999-11-19 | Rhone Poulenc Agrochimie | Nouvelle methode de production de tocopherols dans les plantes et plantes obtenues |
CA2339519A1 (en) * | 1998-08-05 | 2000-02-17 | Sungene Gmbh & Co.Kgaa | Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
-
1999
- 1999-08-11 DE DE19937957A patent/DE19937957A1/de not_active Withdrawn
-
2000
- 2000-07-31 AR ARP000103954A patent/AR029762A1/es unknown
- 2000-08-10 BR BR0013127-0A patent/BR0013127A/pt not_active Application Discontinuation
- 2000-08-10 CA CA002381316A patent/CA2381316A1/en not_active Abandoned
- 2000-08-10 WO PCT/EP2000/007807 patent/WO2001012827A2/de not_active Application Discontinuation
- 2000-08-10 AU AU64409/00A patent/AU6440900A/en not_active Abandoned
- 2000-08-10 EP EP00951492A patent/EP1200598A2/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE19937957A1 (de) | 2001-02-15 |
AU6440900A (en) | 2001-03-13 |
WO2001012827A9 (de) | 2002-05-10 |
WO2001012827A3 (de) | 2001-08-23 |
AR029762A1 (es) | 2003-07-16 |
WO2001012827A2 (de) | 2001-02-22 |
CA2381316A1 (en) | 2001-02-22 |
EP1200598A2 (de) | 2002-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0013127A (pt) | Cassete de expressão, vetor recombinante, microorganismo, planta transgênica, método para gerar plantas transgênicas, usos de um vetor de um microorganismo, de um cassete de expressão, ou de uma planta transgênica, e, processo para a preparação de tocoferóis | |
MX169814B (es) | Composiciones para limpiar superficies duras que contienen derivados de acido iminodiacetico | |
Bartling et al. | A glutathione S‐transferase with glutathione‐peroxidase activity from Arabidopsis thaliana: Molecular cloning and functional characterization | |
BR0115381A (pt) | Processo que permite tornar as plantas tolerantes a um herbicida, polipeptìdeo, sequência de ácido nucléico, sequência de ácido nucléico que codifica uma hpp oxidase, sequência de ácido nucléico que codifica uma hpah, sequência de ácido nucléico que codifica uma hpac, cassete de expressão que compreende uma sequência codificadora, vetor de clonagem e/ou de expressão, célula vegetal transformada, planta transformada, sementes de plantas transformadas, processo de transformação das plantas, processo de capinagem seletiva das plantas, processo de controle das ervas daninhas na superfìcie de um campo e processo de cultura das plantas transformadas | |
Burns et al. | Adenine nucleotides promote dissociation of pertussis toxin subunits. | |
BR9807969A (pt) | ácido nucleico isolado, cassete de expressão, vetor de expressão, célula, planta transgênica, progênie e semente de planta, e, processos para produzir uma planta com nìveis aumentados de um produto de um gene da sìntese de ácidos graxos ou do metabolismo de lipìdeos, uma planta com nìveis aumentados de teor de ácido gama linolênico (gla), para induzir a produção de pelo menos um ácido gama linolênico (gla) ou ácido octadecatetraeÈnico (ota) em uma planta deficiente ou com falta em gla, para diminuir a produção de um gene da sìntese de ácidos graxos ou do metabolismo de lipìdeos em uma planta e para a co-supressão de um gene nativo da sìntese de ácido graxo ou do metabolismo dos lipìdeos em uma planta | |
DK0522880T3 (da) | Gensekvenser som koder for flavonoid pathway enzymer og anvendelse | |
FR2508035B1 (de) | ||
IL101763A (en) | 4-alkylenepiperidine derivatives, their preparation and pharmaceutical compositions containing them | |
ES2112332T3 (es) | Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico. | |
BR9807966A (pt) | ácido nucleico isolado, cassete e vetor de expressão, célula, planta, progênie, semente, processos para produzir uma planta, pra induzir a produção de pelo menos um dentre ácido gama linolênico (gla) ou ácido octadecatetraeÈnico (ota) em uma planta deficiente ou com falta de gla, para diminuir a produção de um gene de sìntese de ácido graxo ou metabolismo de lipìdeo em uma planta, e, para co-suprimir um gene de sìntese de ácido graxo ou metabolismo de lipìdeos nativo em uma planta. | |
ATE311748T1 (de) | Modifizierte formen des natamycins, verfahren zu ihrer herstellung und sie enthaltende antifungale zusammensetzungen | |
ES2031841T3 (es) | Un procedimiento para la preparacion de derivados de 1,1-dioxido de 2-aminoalquil-1,2-benzoisotiazol-3-(2h)ona. | |
BR0213646A (pt) | Método, compostos e composição para controle de pragas invertebradas | |
DK0559079T3 (da) | Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne | |
Schray et al. | Inactivation of muscle triose phosphate isomerase by D-and L-glycidol phosphate | |
Xu et al. | Structural features of the 66-kDa subunit of the energy-transducing NADH-ubiquinone oxidoreductase (NDH-1) of Paracoccus denitrificans | |
DK0635497T3 (da) | Benzospiroalkenderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse | |
AR036178A1 (es) | Genes de la desaturasa del acido graso de la granada y procedimiento para la preparacion de acidos grasos insaturados | |
PT90883A (pt) | Processo de preparacao de 2,3,4,5-tetra-hidro-ih-3-benzazepinas e de composicoes farmaceuticas que as contem | |
HUP9700762A2 (hu) | Vaskötő fehérjét túltermelő stresszrezisztens transzgenikus növények | |
DK314483D0 (da) | Peenem-derivater, fremgangsmade til fremstilling deraf samt deres anvendelse som laegemidler | |
BR0212649A (pt) | Sistema para alcançar elevada expressão gênica | |
DK645589A (da) | Arolyxopropanolaminotetraliner og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende dem | |
PT632028E (pt) | Derivado opticamente activo do 2-nitroimidazole processo para a producao do mesmo e intermediario para a producao do mesmo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |